Insmed revenue and financials
$105.23Change from previous close: +1.35%Absolute change: +$1.40
In the fiscal year ended December 2025, Insmed reported revenue of $606.42M (+66.73% year over year). The net loss was $1.28B.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +66.73%
- 2025 vs 2024
- Net margin
- -210.5%
- 2024: -251.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 425 | 306 | 264 | 142 | 107 | 92.8 | 104 | 93.4 | 90.3 | 75.5 | 83.7 | 79.1 |
| Cost of revenue | 67.2 | 47.4 | 44.2 | 29.4 | 28.1 | 21.3 | 26.2 | 21.2 | 21.0 | 17.5 | 18.4 | 16.7 |
| Gross profit | 358 | 259 | 220 | 113 | 79.3 | 71.5 | 78.3 | 72.3 | 69.4 | 58.0 | 65.3 | 62.4 |
| Selling, general and administrative | 247 | 247 | 212 | 186 | 155 | 148 | 143 | 119 | 107 | 93.1 | 89.5 | 90.6 |
| Research and development | 210 | 209 | 255 | 186 | 177 | 153 | 180 | 151 | 147 | 121 | 137 | 109 |
| Operating income | -101 | -200 | -250 | -261 | -254 | -230 | -245 | -199 | -185 | -157 | -163 | -139 |
| EBIT | -101 | -200 | -250 | -261 | -254 | -230 | -245 | -199 | -185 | -157 | -163 | -139 |
| EBITDA | -96.6 | -196 | -245 | -258 | -251 | -227 | -243 | -197 | -183 | -155 | -160 | -136 |
| Interest expense | 20.3 | 20.1 | 20.6 | 20.4 | 21.2 | 21.6 | 20.7 | 24.9 | 20.9 | 18.7 | 18.8 | 21.6 |
| Pre-tax income | -11.4 | -162 | -327 | -369 | -320 | -256 | -234 | -220 | -300 | -157 | -185 | -158 |
| Income tax | 1.9 | 1.5 | 1.6 | 1.3 | 1.2 | 0.9 | 1.3 | 1.0 | 0.8 | 0.6 | 1.0 | 0.5 |
| Net income | -13.2 | -164 | -328 | -370 | -322 | -257 | -236 | -221 | -301 | -157 | -186 | -159 |
| Net income to common shareholders | -13.2 | -164 | -328 | -370 | -322 | -257 | -236 | -221 | -301 | -157 | -186 | -159 |
| Basic EPS | -0.06 | -0.76 | -1.54 | -1.75 | -1.70 | -1.42 | -1.32 | -1.27 | -1.94 | -1.06 | -1.28 | -1.11 |
| Diluted EPS | -0.06 | -0.76 | -1.54 | -1.75 | -1.70 | -1.42 | -1.32 | -1.27 | -1.94 | -1.06 | -1.28 | -1.11 |
| Average shares (basic) | 217 | 215 | 214 | 212 | 189 | 181 | 179 | 174 | 155 | 148 | 145 | 143 |
| Average shares (diluted) | 217 | 215 | 214 | 212 | 189 | 181 | 179 | 174 | 155 | 148 | 145 | 143 |